Adeptio Pharmaceuticals Limited

The sponsor demonstrates a concentrated interest in developing treatments for dermatological conditions, with particular attention to inflammatory and immune-mediated skin disorders. The research portfolio reflects a commitment to addressing conditions that significantly impact patients' quality of life through visible symptoms and chronic disease burden.

• Atopic Dermatitis and Eczematous Conditions
• Inflammatory Skin Disease Management
• Chronic Dermatological Disorders

The therapeutic development programme encompasses investigations into novel approaches for managing persistent skin conditions, focusing on patients who experience moderate to severe manifestations of inflammatory dermatoses. The research extends to understanding the underlying pathophysiology of skin barrier dysfunction and immune dysregulation in affected populations.